Repotrectinib in a Patient With NTRK Fusion-Positive Pancreatic Carcinoma and Congenital Long QT Syndrome

被引：1
|
作者：
Yun, Karen M. [1 ]
Narezkina, Anna [2 ,3 ]
Redfern, Charles [4 ]
Velasco, Katherine [1 ]
Bazhenova, Lyudmila [1 ]
机构：
[1] UC San Diego Hlth, Moores Canc Ctr, Div Hematol Oncol, 3855 Hlth Sci Dr, La Jolla, CA 92093 USA
[2] Univ Calif Med Ctr, Div Cardiol, La Jolla, CA USA
[3] Sulpizio Cardiovasc Ctr, La Jolla, CA USA
[4] Sharp HealthCare, Med Oncol, San Diego, CA USA
来源：
JCO PRECISION ONCOLOGY | 2024年 / 8卷
关键词：
SOLID TUMORS; LAROTRECTINIB;
D O I：
10.1200/PO.23.00265
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Repotrectinib in a patient with NTRK fusion-positive pancreatic carcinoma and congenital long QT syndrome.
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Real-World Experience of NTRK Fusion-Positive Thyroid Cancer
    Park, Jong Chul
    Ashok, Arya
    Liu, Chienying
    Kang, Hyunseok
    JCO PRECISION ONCOLOGY, 2022, 6
  • [22] Effects of sevoflurane on QT interval in a patient with congenital long QT syndrome
    Gallagher, JD
    Weindling, SN
    Anderson, G
    Fillinger, MP
    ANESTHESIOLOGY, 1998, 89 (06) : 1569 - 1573
  • [23] Oncologist management of NTRK fusion-positive NSCLC improves after virtual patient simulation participation.
    Worst, Michelle Arielle
    Cain, Brittany
    Nelson, Tipp
    Cohen, Jacob
    Drilon, Alexander E.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] Entrectinib in NTRK fusion-positive gastrointestinal cancers: Updated integrated analysis
    Garrido-Laguna, I.
    Lonardi, S.
    Bazhenova, L.
    Peeters, M.
    Longo, F.
    Sigal, D.
    Conkling, P.
    Duffaud, F.
    Klingbiel, D.
    Bordogna, W.
    Ciardiello, F.
    ANNALS OF ONCOLOGY, 2022, 33 : S370 - S371
  • [25] Primary Resistance to RET Inhibition in a RET Fusion-Positive Pancreatic Neuroendocrine Carcinoma
    Mckinley, Blake J.
    Coston, Tucker W.
    Starr, Jason S.
    ONCOLOGIST, 2024,
  • [26] Updated efficacy and safety of entrectinib in patients (pts) with NTRK fusion-positive (NTRK-fp) NSCLC
    Cho, B. C.
    Chiu, C-H.
    Massarelli, E.
    Chawla, S. P.
    Buchschacher, G. L., Jr.
    Goto, K.
    Kim, S-W.
    Overbeck, T. R.
    Loong, H. H. F.
    Chee, C. E.
    Garrido, P.
    Heinzmann, S.
    Pitcher, B.
    John, T.
    ANNALS OF ONCOLOGY, 2022, 33 : S82 - S83
  • [27] Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer
    Drilon, Alexander
    Camidge, D. Ross
    Lin, Jessica J.
    Kim, Sang-We
    Solomon, Benjamin J.
    Dziadziuszko, Rafal
    Besse, Benjamin
    Goto, Koichi
    de Langen, Adrianus Johannes
    Wolf, Juergen
    Lee, Ki Hyeong
    Popat, Sanjay
    Springfeld, Christoph
    Nagasaka, Misako
    Felip, Enriqueta
    Yang, Nong
    Velcheti, Vamsidhar
    Lu, Shun
    Kao, Steven
    Dooms, Christophe
    Krebs, Matthew G.
    Yao, Wenxiu
    Beg, Muhammad Shaalan
    Hu, Xiufeng
    Moro-Sibilot, Denis
    Cheema, Parneet
    Stopatschinskaja, Shanna
    Mehta, Minal
    Trone, Denise
    Graber, Armin
    Sims, Gregory
    Yuan, Yong
    Cho, Byoung Chul
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (02): : 118 - 131
  • [28] Uterin spindle cell mesenchymal neoplazm, NTRK fusion-positive uterine sarcoma
    Konuk, B.
    Topal, C. S.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S264 - S264
  • [29] Canadian consensus on TRK-inhibitor therapy for NTRK fusion-positive sarcoma
    Simmons, Christine
    Deyell, Rebecca J.
    MacNeill, Andrea J.
    Vera-Badillo, Francisco E.
    Smrke, Alannah
    Abdul Razak, Albiruni R.
    Banerji, Shantanu
    McLeod, Deanna
    Noujaim, Jonathan
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (09) : 1691 - 1704
  • [30] DIFFERENTIAL OF SYNCOPE AND EPILEPSY IN A PATIENT WITH CONGENITAL LONG QT SYNDROME
    Takahashi, Yoshimi
    Fujita, Hiroshi
    Yamanaka, Shinsuke
    Hayashi, Hideka
    Shinozaki, Tsuyoshi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1233 - 1233
12345